Parx Materials logo — Harnessing biomimetic innovation to create 100% safe, biocom...

Parx Materials

Harnessing biomimetic innovation to create 100% safe, biocompatible antibacterial plastics, ensuring protection for humans, animals, and the environment.

Founded 2012 The Netherlands The Netherlands 4 employees Non Equity Assistance Biotechnology, Health Care +1

General Information

Company Name Parx Materials
Founded Year 2012
Location The Netherlands The Netherlands
Employees 4
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Parx Materials. To contact Parx Materials, visit parxmaterials.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Parx Materials compare?

A PDF of Parx Materials and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Parx Materials soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Parx Materials

Parx Materials is a Netherlands-based biotech startup founded in 2012 with a focus on developing innovative antibacterial plastics. The company's slogan, "Harnessing biomimetic innovation to create 100% safe, biocompatible antibacterial plastics, ensuring protection for humans, animals, and the environment," reflects its core mission. Parx Materials aims to address the challenges posed by bacteria and viruses by leveraging bio-inspired technology that creates hygienic surfaces, reducing the presence of microorganisms by 99.9% and higher, while ensuring ecological and biodiversity safety. Notably, the company's approach differs from traditional methods reliant on biocides and antibiotics, as Parx Materials uses a body's own trace element incorporated into materials without inducing antimicrobial resistance. Their technology effectively controls colonization by bacteria and viruses by preventing adhesion and biofilm formation, without the use of biocides. Parx Materials' commitment to sustainability and innovation has garnered attention, with MassChallenge providing Non-Equity Assistance investment in October 21, 2020. This unique positioning has positioned Parx Materials as a groundbreaking player in the biotechnology, healthcare, and manufacturing industries, setting the stage for the company's continued growth and influence. Moreover, by being stock listed on Euronext Access in Paris under the ticker symbol MLPRX, Parx Materials has underscored its commitment to transparency and accessibility, further bolstering its appeal to potential investors and partners.

Business keywords: Biomimetic innovation, Antibacterial plastics, Biocompatible materials, Nano- and biotechnologies, Chemical analysis, Biomedical research, Environmental safety, Innovative materials, Antimicrobial effectiveness, Research and development, Patent-pending technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
MassChallenge
21 Oct 2020

Parx Materials Alternatives & Competitors

View All Alternatives
Parx Materials vs
Aja Labs
Aja Labs United States

Bio-intelligent fibers engineered for performance, safety, and scale

Seed
11 employees
Biotechnology, Manufacturing
Parx Materials vs

Innovative nanoparticles for everlasting, safe, and cost-effective antimicrobial solutions across va...

Venture round
Biotechnology, Manufacturing
Parx Materials vs

Discover the future of cancer treatment with our innovative blood purification technology that targe...

Series A
2-10 employees
Biotechnology, Health Care

FAQ About Parx Materials

Harnessing biomimetic innovation to create 100% safe, biocompatible antibacterial plastics, ensuring protection for humans, animals, and the environment.
Parx Materials was founded in 2012.
Parx Materials is headquartered in The Netherlands.
Parx Materials operates in Biotechnology, Health Care and Manufacturing. Its work centres on Biomimetic innovation, Antibacterial plastics, Biocompatible materials and Nano- and biotechnologies.
Parx Materials has approximately 4 employees.
Parx Materials has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Parx Materials include Aja Labs, NanoHorizons, BioPheresis, Westway Health, Sparxell. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Parx Materials and Aja Labs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Parx Materials, https://bouncewatch.com/company/parx-materials, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes